SG Americas Securities’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

SG Americas Securities’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-50,354	Closed	-$2.08M	–	3028
2015 Q2	$2.08M	Buy	+50,354	New	+$1.81M	0.01%	709
2015 Q1	–	Sell	-6,043	Closed	-$194K	–	3391
2014 Q4	$194K	Buy	+6,043	New	+$175K	﹤0.01%	2451
2013 Q4	–	Sell	-6,417	Closed	-$192K	–	3328
2013 Q3	$192K	Buy	+6,417	New	+$178K	﹤0.01%	2214

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

SG Americas Securities's BRLI Position: Q3 2015 in Review

SG Americas Securities sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 50,354 shares — an estimated $2.08M sold.

SG Americas Securities first reported a position in BRLI in Q3 2013 and held it in 3 quarters. The position peaked at $2.08M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

SG Americas Securities reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
SG Americas Securities sold 50,354 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.08M.
SG Americas Securities first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 3 quarters.
SG Americas Securities's BIO-REFERENCE LABS INC-NEW- position peaked at $2.08M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on SG Americas Securities's 13F filing for Q3 2015, filed 9 Nov 2015.